Urogen

JELMYTO

Manufacturer:

Urogen

Jelmyto HCPCS:

J9281

HCPCS Code Descriptor:

Mitomycin pyelocalyceal instillation, 1 mg

Category:

J Code

Jelmyto NDCs:

72493-0103-03

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Injection

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Jelmyto:

JELMYTO is an Oncology drug manufactured by Urogen and administered via the Injection route of administration. The J Code: J9281 is aligned to the drug JELMYTO.

ACCESS PRICING AND MORE BY REGISTERING

J9281 Added Date:

January 1, 2021

J9281 Effective Date:

January 1, 2021

J9281 Termination Date:

HCPCS Active

Jelmyto billing and coding information can be found through Urogen at the link below:
Jelmyto patient assistance information can be found through UroGen Support at the URL: https://www.jelmyto.com/hcp/support/
JELMYTO prescribing information can be found at the link below:
Information regarding JELMYTO’s side effects can be found at MedlinePlus